Picture of Zylox-Tonbridge Medical Technology Co logo

2190 Zylox-Tonbridge Medical Technology Co Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapSucker Stock

Annual income statement for Zylox-Tonbridge Medical Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M
Source:PROSPECTUSPROSPECTUSARS
Standards:
IFRS
IFRS
IFRS
Status:FinalFinalFinal
Revenue
Total Revenue4.9227.6178
Cost of Revenue
Gross Profit1.1916.3132
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses70.6128390
Operating Profit-65.7-100-212
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-66.6-100-200
Provision for Income Taxes
Net Income After Taxes-66.6-100-200
Net Income Before Extraordinary Items
Net Income-66.6-100-200
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-66.6-100-200
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.201-0.302-0.601

Or unlock with your email

Or unlock with your email